Reduced-intensity conditioning therapy with fludarabine, idarubicin,busulfan and cytarabine for allo

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:tina_xu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
We retrospectively analyzed allogenic stem cell transplantation (allo-SCT) outcomes in 82 patients with AML or MDS were conditioned with udarabine,idarubicin,intravenous-busulfan and cytarabine (FIBA) or busulfan and cyclophosphamide (BuCy).
其他文献
This study included data from 185 consecutively treated patients,16 years of age or older,who underwent myeloablative transplantation using unrelated UCB (UCBT,n=70) or HLA-identical sibling donor per
会议
Chemotherapy can increase treatment-related mortality associated with future hematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukemia (AML).There is
会议
Objective Observe the clinical effect of haploidentical HSCT (haplo-HSCT) to treat pediatric leukemia.Method During July 2007 to September 2011,24 children were subjected in haploidentical HSCT.Then,t
会议
Aim Retrospectively analyzethe role of sequential autologous stem cell transplantation (ASCT) in aggressive NHL.Method 121 newly diagnosed patients with aggressive NHL,including 68 males and 53 female
会议
Background Aggressive T-cell lymphomas represent 10 %to 15 %of non-Hodgkins lymphomas in adults.Patients withrelapsed or refractory disease are generally considered incurable with conventional therapi
会议
Background The effects of donor characteristics on CD34+ cell dose remains controversial.Recently,we developed a novel haploidentical transplant protocol,in which mixture allografts of granulocyte col
会议
Objective To investigate the outcome of autologous hematopoietic stem cell transplantation(auto-HSCT) for patients with acute myeloid leukemia(AML),we retrospectively compared the outcomes of auto-HSC
会议
Object The treatment for progressive hematologic malignancies is dismal,but few clinical studies have investigated the role of salvaged unrelated cord blood transplantation (CBT) for these patients.
会议
Objective Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immune deficiency (PID) characterized by micro-thrombocytopenia,eczema,and impaired cellular and humoral immunity.WAS is associated
会议
This study evaluates the prognostic significance of quantitative chimerism to monitor minimal residual disease and predict relapse in acute leukemia (AL) patients following allogeneic hematopoietic st
会议